Senior insider sale
Chief Financial Officer at ARCUS BIOSCIENCES, INC. — senior position signals high conviction
$199.0K
7.76K shares
What this filing means
GOELTZ II ROBERT C. plans to sell 7.76K shares of ARCUS BIOSCIENCES, INC. valued at approximately $199.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/11/2026ACC: 0001628280-26-033690
Officer· Chief Financial Officer
Since Aug 2020
7.76K
Shares to sell
$199.0K
Approx. market value
7.76K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Restricted Stock Unit
Equity Compensation
12/15/2024
7.31KRestricted Stock Unit
Equity Compensation
12/15/2022
456.00Total acquired7.76K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
12/15/2024 | Restricted Stock Unit Equity Compensation | 7.31K | — |
12/15/2022 | Restricted Stock Unit Equity Compensation | 456.00 | — |
| Total | 7.76K | ||
Planned & Completed Dispositions1
NYSEPlanned
Units to sell
7.76K
Market value
$199.0K
5/11/2026
Total
Units
7.76K
Value
$199.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/11/2026 | 7.76K | $199.0K | NYSE | Planned |
| Total | 7.76K | $199.0K | ||